0001387131-16-005689.txt : 20160526
0001387131-16-005689.hdr.sgml : 20160526
20160526120807
ACCESSION NUMBER: 0001387131-16-005689
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20160525
FILED AS OF DATE: 20160526
DATE AS OF CHANGE: 20160526
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Ohr Pharmaceutical Inc
CENTRAL INDEX KEY: 0001173281
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 465622433
STATE OF INCORPORATION: DE
FISCAL YEAR END: 0930
BUSINESS ADDRESS:
STREET 1: 800 THIRD AVENUE
STREET 2: 11TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10022
BUSINESS PHONE: (212) 682-8452
MAIL ADDRESS:
STREET 1: 800 THIRD AVENUE
STREET 2: 11TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10022
FORMER COMPANY:
FORMER CONFORMED NAME: BBM HOLDINGS, INC.
DATE OF NAME CHANGE: 20070402
FORMER COMPANY:
FORMER CONFORMED NAME: PRIME RESOURCE INC
DATE OF NAME CHANGE: 20020513
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Slakter Jason Scott
CENTRAL INDEX KEY: 0001630109
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35963
FILM NUMBER: 161677022
MAIL ADDRESS:
STREET 1: 57 MEADOW WOODS ROAD
CITY: GREAT NECK
STATE: NY
ZIP: 11020
4
1
slakter-form4_052516.xml
OWNERSHIP DOCUMENT
X0306
4
2016-05-25
0
0001173281
Ohr Pharmaceutical Inc
OHRP
0001630109
Slakter Jason Scott
C/O OHR PHARMACEUTICAL INC.
800 THIRD AVE, 11TH FLOOR
NEW YORK
NY
10022
1
1
0
0
Chief Executive Officer
Common Stock, par value $0.0001 per share
2016-05-25
4
P
0
500
3.09
A
913072
D
Common Stock, par value $0.0001 per share
2016-05-25
4
P
0
100
3.11
A
913172
D
Common Stock, par value $0.0001 per share
2016-05-25
4
P
0
300
3.14
A
913472
D
Common Stock, par value $0.0001 per share
2016-05-25
4
P
0
100
3.1399
A
913572
D
Common Stock, par value $0.0001 per share
2016-05-25
4
P
0
682
3.13
A
914254
D
Common Stock, par value $0.0001 per share
2016-05-25
4
P
0
2000
3.10
A
916254
D
Common Stock, par value $0.0001 per share
697865
I
By SKS Ocular I LLC
SKS Ocular I LLC directly owns the shares of Common Stock. On May 30, 2014, the Issuer completed an ophthalmology assets acquisition of SKS Ocular LLC and SKS Ocular I LLC. Pursuant to the acquisition agreement, among other things, SKS Ocular I LLC is eligible to receive additional shares of Common Stock in three contingent milestone payments. Milestone 1 has been met and on December 15, 2015, the Issuer issued 497,859 shares of Common Stock to SKS Ocular I LLC. The Reporting Person has investment and voting power with respect to the Common Stock held by SKS Ocular 1 LLC. Therefore, the Reporting Person may be deemed to beneficially own the shares of Common Stock beneficially owned by SKS Ocular 1 LLC. The Reporting Person disclaims any beneficial ownership of the Common Stock directly owed by SKS Ocular I LLC except to the extent of his pecuniary interest therein.
/s/ Jason Scott Slakter
2016-05-26